İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

EMRE ÖZGENÇ

DOKTOR ÖĞRETİM ÜYESİ (Unvan:Doçent)

EGE ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK TEKNOLOJİSİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Radyofarmasi

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 31
  • Proje 0
  • Kitap 5
  • Bildiri 14
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 7 Q2 9 Q3 11 Q4 1
WoS (JCR) Q1 5 Q2 10 Q3 3 Q4 5
TR Index 6 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 0
Ort. yüzdelik 71.0%
Üst %1 payı 0.0%
Üst %10 payı 0.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 31 yayın

Makale listesi

  1. 2026 Development and quality control studies of radiolabelled nanostructured lipid formulations with Ga-68 Applied Radiation and Isotopes DOI 10.1016/j.apradiso.2026.112453 YÖKSİS SJR Q2 JCR Q2
  2. 2026 CHARACTERIZATION OF LEUCO METHYLTHIONINIUM BIS-CONTAINING NANOPARTICLES FOR ALZHEIMER’S DIAGNOSIS Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1571470 YÖKSİS SJR Q3
  3. 2025 Preparation, Optimization, and Stability of Isosulfan Blue-Loaded Human Serum Albumin-Structured Nanocolloids ACS Omega DOI 10.1021/acsomega.5c02567 YÖKSİS SJR Q1 JCR Q2
  4. 2025 Development and evaluation of 177Lu-imatinib: radiolabeling and cell culture studies Radiochimica Acta DOI 10.1515/ract-2025-0043 YÖKSİS SJR Q4 JCR Q3
  5. 2024 99mTc‐labeled, tofacitinib citrate encapsulated chitosan microspheres loaded in situ gel formulations for intra‐articular treatment of rheumatoid arthritis Drug Development Research DOI 10.1002/ddr.22247 YÖKSİS SJR Q2 JCR Q1
  6. 2024 Radiolabeling, Characterization, And In Vitro Cell Culture Studies of Donepezil-Loaded Niosome Formulations For Brain Imaging Fabad Journal of Pharmaceutical Sciences DOI 10.55262/fabadeczacilik.1385224 YÖKSİS SJR Q3
  7. 2024 PREPARATION OF LIPID NANOCARRIER FORMULATIONS AND CYTOTOXICITY STUDIES OF DONEPEZIL Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1400158 YÖKSİS SJR Q3
  8. 2024 PREPARATION OF LIPID NANOCARRIER FORMULATIONS AND CYTOTOXICITY STUDIES OF DONEPEZIL Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1400158 YÖKSİS SJR Q3
  9. 2023 Evaluation of F-18 FDG radiopharmaceuticals through Molecular Docking and radiation effects Applied Radiation and Isotopes DOI 10.1016/j.apradiso.2022.110553 YÖKSİS SJR Q3 JCR Q2
  10. 2023 68Ga‐labeled, imatinib encapsulated, theranostic liposomes: Formulation, characterization, and in vitro evaluation of anticancer activity DRUG DEVELOPMENT RESEARCH DOI 10.1002/ddr.22136 YÖKSİS SJR Q2 JCR Q2
  11. 2023 99mTc-Labeled, Colistin Encapsulated, Theranostic Liposomes for Pseudomonas aeruginosa Infection AAPS PharmSciTech DOI 10.1208/s12249-023-02533-8 YÖKSİS SJR Q2 JCR Q2
  12. 2023 Radiolabeling, Quality Control, and Cell Binding Studies of New 99mTc-Labeled Bisphosphonates: 99mTc-Ibandronate Sodium Turkish Journal Of Pharmaceutical Sciences DOI 10.4274/tjps.galenos.2022.01346 YÖKSİS TR Index SJR Q2 JCR Q3
  13. 2022 Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today? Pharmaceutics DOI 10.3390/pharmaceutics14112425 YÖKSİS SJR Q1 JCR Q1
  14. 2022 An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake, and Cytotoxicity Studies Nanomaterials DOI 10.3390/nano12020250 YÖKSİS SJR Q1 JCR Q1
  15. 2022 Pre-clinic study of radiopharmaceutical for Covid-19 inactivation: Dose distribution with Monte Carlo Simulation Applied Radiation and Isotopes DOI 10.1016/j.apradiso.2022.110364 YÖKSİS SJR Q3 JCR Q2
  16. 2022 Radiolabeled Trastuzumab Solid Lipid Nanoparticles for Breast Cancer Cell: in Vitro and in Vivo Studies ACS Omega DOI 10.1021/acsomega.2c03023 YÖKSİS SJR Q1 JCR Q2
  17. 2022 Polymer Based Gels: Recent and Future Applications in Drug Delivery Field Current Drug Delivery DOI 10.2174/1567201819666220907124040 YÖKSİS SJR Q2 JCR Q3
  18. 2022 Pre-Study on Radiolabeling of Colistin with Lutetium-177 to Develop Theranostic Infection Agent Journal of Research in Pharmacy DOI 10.29228/jrp.137 YÖKSİS TR Index SJR Q3 JCR Q4
  19. 2022 Development and radiolabeling of lipid nanoparticles with [99mTc]Tc-HMPAO: Characterization, stability, cytotoxicity and cell-binding studies Journal of research in pharmacy (online) DOI 10.29228/jrp.106 YÖKSİS TR Index SJR Q3 JCR Q4
  20. 2022 Development and Radiolabeling Evaluation of 177 Lutetium-Tedizolid FABAD Farmasotik Bilimler Ankara Dernegi DOI 10.55262/fabadeczacilik.1099287 YÖKSİS SJR Q3

Akademisyenlere dön